Identifyn® LLC, a frontrunner in super-resolution applications and discovery tools, has achieved a significant milestone with the successful completion of antibody validation in flow cytometry. This endeavor was executed in collaboration with SuaveBio, a respected independent biotech firm specializing in flow cytometry, based in Worcester, Massachusetts.
Importance of Antibody Validation
Antibody validation in flow cytometry is a critical step in ensuring that antibodies accurately detect their specific target antigens. This process is vital for obtaining reliable and reproducible results in scientific research. Validation involves several rigorous steps, including proper titration and in-house verification, to confirm that antibodies perform as expected under various biological models and experimental conditions.
Acknowledgment of Achievement
“This marks another important achievement for Identifyn as we showcase the exceptional quality of our product line to the scientific community,” expressed Todd Wyman, CEO and Co-Founder of Identifyn®. He emphasized the company’s mission to develop antibody products that address significant challenges faced by scientists, ultimately saving valuable resources and improving patient outcomes.
Key Findings from Validation Studies
In the validation studies conducted by SuaveBio, Identifyn’s anti-mouse, rabbit, and rat secondary antibodies exhibited impressive signal-to-noise ratios along with minimal cross-reactivity. Such characteristics are essential for high-sensitivity applications in flow cytometry. The study also highlighted that the BRCA1 and PARP1 primary antibodies provided sharp and specific staining, while the secondary antibodies retained remarkable stability and brightness.
Competitive Edge in the Market
According to Hannah Sheehan, Ph.D., Co-Founder and CEO of SuaveBio, Identifyn’s direct conjugates were benchmarked against leading competitors, demonstrating superior specificity and a more robust signal. The study concluded that these reagents were ready to use immediately, making them an excellent choice for workflows that demand precise and reliable detection.
About Identifyn® LLC
Identifyn® LLC is a pioneer in providing advanced discovery tools for immunofluorescent biological investigations. Founded on the principles of context, precision, and reproducibility, the company combines high-resolution imaging, chemistry, validation, and artificial intelligence to push the boundaries of what is achievable in spatial biology. By fostering innovation and collaboration, Identifyn® equips scientists with the tools they need to visualize and comprehend biological processes like never before.
Looking Ahead
The successful validation of these antibodies not only reinforces Identifyn’s commitment to quality but also sets a new standard in the field of flow cytometry. This achievement is expected to enhance the company’s reputation and position as a trusted partner in scientific research.
Key Takeaways
- Identifyn® has successfully completed antibody validation in flow cytometry with SuaveBio.
- Antibody validation ensures specific detection of target antigens, crucial for reliable research outcomes.
- The validation showcased Identifyn’s products as superior in terms of specificity and signal strength compared to competitors.
- Identifyn® continues to lead through innovation, combining advanced technologies for enhanced biological research.
In conclusion, Identifyn® LLC’s recent accomplishment in antibody validation represents a significant leap forward in flow cytometry research. This milestone not only underscores the company’s dedication to quality and precision but also promises to enhance scientific discovery and innovation across the biomedical landscape.
Read more → www.tennessean.com